Potential Association Between Anabolic Androgenic Steroid Abuse and Pituitary Apoplexy: A Case Report.
Fiche du document
2022
- doi: 10.3389/fendo.2022.890853
- issn: 1664-2392
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3389/fendo.2022.890853
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35937816
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1664-2392
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_01F23C650CD30
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
CaseCiter ce document
A. Andriuskeviciute et al., « Potential Association Between Anabolic Androgenic Steroid Abuse and Pituitary Apoplexy: A Case Report. », Serveur académique Lausannois, ID : 10.3389/fendo.2022.890853
Métriques
Partage / Export
Résumé
Pituitary apoplexy (PA) is a rare, and potentially life-threatening condition, caused by hemorrhage or infarction into the pituitary gland with a rapid expansion of the contents of the sella turcica, associated with sudden intense headache, neurological and endocrinological deterioration. The identification of risk factors is crucial for prevention and optimal management. Herein we report a case of PA occurring 1 month after the initiation of anabolic androgenic steroid abuse for bodybuilding. A 40-year-old male patient presents with abrupt onset headache associated with left partial third cranial nerve palsy. The MRI shows a sellar lesion involving left cavernous sinus with a heterogenous anterior aspect of the lesion with hemorrhagic zones in favor of PA. Endocrine work-up shows high testosterone level in patient who was using exogenous testosterone without a medical prescription for a month. We report a case of PA of a pituitary neuroendocrine tumor occurring shortly after AAS. The association between PA and AAS should be considered as a potential risk.